Critical Technology Assessment for biopharmaceuticals

Critical Technology Assessment for biopharmaceuticals

Report

Critical Technology Assessment for biopharmaceuticals

In October 2023, Marta Wosińska and Rena Conti concluded a one-year pilot demonstration of how analytics can inform national technology strategy in biopharmaceuticals. Their demonstration was part of a large, cross-industry pilot titled the National Network for Critical Technology Assessment.

  • Use cases, geography and tags
  • Organizations that created, adopted or are mentioned
  • Ecosystem position
  • Link to the original asset
  • Comments and reactions